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Abstract 
Background: Neurodevelopmental disorders have a prevalence of approximately 
3% in the population, the genetic factor is involved in this condition. Microdeletions 
that comprise the 2q14.1q14.3 region are rare events. The aim of the study: To de-
scribe a girl with an interstitial deletion of the 2q14 region with a severely affected 
phenotype and to compare her with reports from the international literature. Materi-
als and methods: Cell culture and the obtaining of chromosomes were carried out 
according to the standardized techniques in our laboratory. Results: Girl evaluated 
for dismorphias and brain malformation (corpus callosum agenesis). The chromoso-
mal study with a resolution of 565 bands showed an interstitial deletion in the long 
arm of chromosome 2. Karyotype: 46, XX, del (2) (q14.1q14.2). Conclusion: The 
correct clinical analysis of the patient and the high-resolution cytogenetic technique 
has been successful for detection of the microdeletion in this case helping in genetic 
counseling and in elucidating the genetic origin of the patient's neurodevelopmental 
disorder.  
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Introduction. Neurodevelopmental 
disorders (NDD) have an estimated preva-
lence of about 3% in worldwide population 
and they are considered a health problem in 
countries with a well-implemented public 
health service. This condition has a high inci-
dence of the genetic factor, since about 28% 
of patients with NDD present some type of 
abnormality in their genome [1]. Until present 
date, up to 450 different genes have been de-
scribed and found t to be directly involved in 
NDD, and it is estimated that many more are 
to be discovered [2]. Numerous microdele-
tion-microduplication syndromes (MMSs) 
involving new genes have been identified us-
ing molecular methods and a high-resolution 
technique on chromosomes. For most NDD 
cases, intellectual disability has been found to 
be the most common feature [3]. 
Microdeletions that comprise the 
2q14.1q14.3 chromosomal region are rare 
events. Until present date, the reviewed litera-
ture only reports nine similar cases, some 
with large deletions of more than 20 Mb, and 
others with cryptic deletions smaller than 6 
Mb that are not detected by conventional cy-
togenetics. Depending on the extension and 
location of the lost segment in this region, the 
phenotype of the patients may be subject to 
variability. However, there are characteristics 
common to most affected individuals, such as: 
intellectual disabilities of different degrees, 
postnatal growth retardation and facial dys-
morphism [4]. 
The aim of the study. In the present 
study we describe a case with an interstitial 
deletion of the 2q14 region, de novo, in a girl 
with a severely affected phenotype and com-
pare it with reports found in international lit-
erature. 
Materials and methods. Cell culture 
and the obtaining of chromosomes were 
carried out according to the standardized 
techniques in our laboratory. Chromosome 
analysis is performed with a resolution greater 
than 550 bands. 
Results and discussion. The girl evalu-
ated for dysmorphia and brain malformation 
was born by caesarean section due to pelvic 
cephalous disproportion at 39 weeks‘ gesta-
tion. 
First daughter of non-consanguineous 
couple, there is no pathological history in the 
family. Follow-up during pregnancy with 
normal alpha fetoprotein analysis and ultra-
sound during the third trimester present an 
apparent macrocephaly and dilatation of the 
ventricular system. 
At birth, height and weight were ade-
quate for gestational age. During postnatal 
follow-up, hypotonia and poor sucking reflex 
were noted. The girl was admitted to neona-
tology for omphalitis. The girl was examined 
by specialists who diagnosed the symptoms of 
sustained hypotonia. 
Physical examination at four months of 
age showed facial dysmorphias such as hyper-
telorism, a depressed nasal bridge, anteverted 
nostrils, a wide anterior fontanel and an open 
posterior fontanelle. Normal hematological 
parameters. 
Transfontanelle ultrasound: a dilatation 
of the ventricular system and absence of the 
corpus callosum were detected. 
Skull IMR: cerebral malformation with 
poor differentiation between white and gray 
matter, hydrocephalus and absence of the cor-
pus callosum. 
Karyotype 
By means of a chromosomal study with 
a resolution of 565 bands, an interstitial dele-
tion in the long arm of chromosome 2 
(46, XX, del (2) (q14.1q14.2) was diagnosed. 
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Fig. Partial karyotype of the girl with the insertional deletion 2q14.1-q14.2 
The parents have a normal phenotype, the chromosomal studies of both were normal. 
Genotype - Phenotype Correlation 
The patients in Table 1 share pheno-
types that indicate malformations in the struc-
tural organization of the nervous system. A 
spectrum from large malformations that in-
clude the ventricular system to defects that 
cause the absence of the corpus callosum is 
observed in all patients. Furthermore, a series 
of common phenotypic characteristics are 
present, such as: growth retardation, promi-
nent forehead, hypertelorism, depressed nasal 
bridge and intellectual disability. 
A girl with severe neurodevelopmental 
disorders and other large malformations, such 
as corpus callosum agenesis, is described. 
Additionally, she presents several dysmorphic 
features and an unusual interstitial deletion in 
2q14 which was diagnosed by high-resolution 
methods. A comparison with similar cases 
reported in the literature has been made to de-
fine affected genes which are responsible for 
the  phenotype. 
Gomumy et al. (2016) report the case of 
a boy and his brother with a deletion of the 
2q14.1q14.3 segment diagnosed by microar-
ray studies. According to these authors, the 
deleted area comprises 5.8 Mb of the genome 
and contains 79 genes, of which 24 are coding 
and three genes are described in the OMIM as 
morbid genes, due to their haploinsufficiency: 
STEAP3, GLI2, and RNU4ATAC [4]. 
The STEAP3 gene has a role as a metal 
reducer and participates in the homeostasis of 
iron present in erythrocytes. The deficiency of 
this gene causes microcytic-hypochromic 
anemia [5]. The two patients reported by Go-
mumy and the one described in present study 
had no clinical signs of hypochromic anemia. 
This suggests that this gene is not found with-
in the deleted genes in our patient. 
The GLI2 gene encodes a protein 
which, when deficient, for instance due to a 
mutation has been associated with characteris-
tics of the spectrum of holoprosencephaly and 
has great phenotypic variability (including 
Краткое сообщение 
Short communication 
Alvarez YB, et al. 2q14 de novo interstitial deletion in a girl with … 305 
abnormalities in the formation of the pituitary 
gland and craniofacial abnormalities) [6]. 
Also in these patients, agenesis of the corpus 
callosum has been reported [7]. The patient 
reported in this study presents marked hyper-
telorism, which does not correspond to the 
holoprosencephaly referred in these cases. It 
is very likely that this gene is not deleted in 
the patient described here. 
The RNU4ATAC gene encodes a small 
nuclear RNA involved in the activity of cor-
rect splice and separation of introns to form 
messenger RNA. Mutations of this gene lead 
to intron splicing errors of approximately 800 
types of U12 introns involved in a wide varie-
ty of cellular processes [8]. These alterations 
cause Taibi-Linder syndrome characterized by 
pre and post-natal growth retardation, micro-
cephaly, severe brain malformations, dys-
morphic features, bone dysplasia and hearing 
and vision defects. Due to this mutation in the 
RNU4ATAC gene, all patients have partial or 
complete absence of the corpus callosum [9] 
This major malformation is present in our pa-
tient and coincidentally is associated with the 
haploinsufficiency of the gene previously de-
scribed. In addition, other phenotypic charac-
teristics of the case in question coincide with 
those of patients who carry mutations in the 
RNU4ATAC gene (Table). 
Table 
Comparison of the patient´s phenotype with internationally reported cases 
Features Index case 
Kordaᵝ et al 
2015 [10] 
Goumy et al. 
2016 [6] 
Goumy et al. 
2016 [6] 













Sex F F M M F 
Age 4 months 25 year old 6 months 2 year old 14  year old 
Neurodevelopme
ntal disorder 
X X X x 
Growth 
retardation 
X X X X x 
Prominent 
forehead 
X X X 
Microcephaly X X 
Hypertelorism X x x X 
Depressed nasal 
bridge 









Corpus callosum agenesis has been de-
scribed as a consequence of large deletions 
including the 2q14 region. Antich et al. [12] 
describes the deletion from 2q12-q14, Fryd-
man et al. [13] from 2q14-q21 and Greally et 
al. [14] from 2q14-q22.1. The latter has found 
this malformation in two of the 9 patients he 
reports. Another characteristic present in pa-
tients with deletion in the 2q14 region is the 
growth retardation that has also been found in 
patient under study. Greally et al suggested 
that it was due to haploinsufficiency of the 
GLI2 gene [14]. 
Kordaᵝ et al. [10] describe a family with 
the small deletion of 4.3 Mb in the 2q14.2 re-
gion that includes the GLI2 and RNU4ATAC 
genes. Several dysmorphic features are de-
scribed but none belonging to the spectrum of 
holoprosencephaly. The authors confirm that 
it is due to the incomplete penetrance that 
characterizes the GLI2 gene mutations [6, 15]. 
The family described by Korda et al. does not 
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present intellectual disability and in the index 
case the most striking was the postnatal 
growth retardation, a feature that is also pre-
sent in this girl. 
Even when the limitations of the meth-
od used to make the diagnosis in the present 
case are recognized, the karyotype-phenotype 
correlation and its coincidence with the re-
ports in the scientific literature suggest that 
the detected deletion in the 2q14 region is a 
certain possibility for a correct diagnosis of 
this case. Agenesis of the corpus callosum 
does not occur in all the patients reported in 
the consulted literature, perhaps due to the 
phenomenon of incomplete penetration of The 
GLI2 gene or perhaps because the 
RNU4ATAC gene is not affected by the dele-
tion, which is a possibility still to be defined.  
Since this major malformation is pre-
sent in this patient, confirmation of the diag-
nosis by more precise molecular methods is 
recommended in order to classify this case as 
example of a 2q14 deletion and to define a 
possible MMS with this designation in the 
future. 
Conclusions. The correct clinical 
analysis of the patient and the high-resolution 
cytogenetic technique has been successful for 
detection of the microdeletion in this case 
helping in genetic counseling and in 
elucidating the genetic origin of the patient's 
neurodevelopmental disorder. 
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